AZN Dividend History & Analysis | 1.7% Yield
AZN has a dividend yield of 1.7% and paid 3.23 USD per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| SUPN NASDAQ Supernus Pharmaceuticals |
1,523 M | 28.68% | 66.95% |
| BMY NYSE Bristol-Myers Squibb |
127,020 M | 4.38% | 5.20% |
| TAK NYSE Takeda Pharmaceutical |
67,157 M | 3.83% | 6.03% |
| NVS NYSE Novartis |
305,825 M | 3.06% | 7.00% |
| GSK NYSE GSK |
100,885 M | 3.53% | 5.15% |
| NOVN SW Novartis |
304,039 M | 2.99% | 6.19% |
| VTRS NASDAQ Viatris |
21,789 M | 3.50% | 4.26% |
| MRK NYSE Merck |
362,526 M | 2.89% | 4.73% |
| ORNBV HE Orion |
15,884 M | 2.38% | 5.56% |
| RO SW Roche Holding |
391,724 M | 3.26% | 3.16% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLUN-B CO H Lundbeck |
9,003 M | 26.64% | 100.0% |
| SECT-B ST Sectra (publ) |
6,153 M | 26.84% | 99.0% |
| FAGR BR Fagron |
1,970 M | 18.76% | 100.0% |
| LLY NYSE Eli Lilly |
1,215,626 M | 15.25% | 100.0% |
| TUB BR Tubize-Fin |
12,148 M | 9.60% | 100.0% |
| NVS NYSE Novartis |
305,825 M | 8.79% | 100.0% |
| MRK NYSE Merck |
362,526 M | 5.34% | 100.0% |
| RPRX NASDAQ Royalty Pharma |
39,044 M | 5.31% | 100.0% |
| IPN PA Ipsen |
14,246 M | 7.55% | 98.0% |
| JNJ NYSE Johnson & Johnson |
664,947 M | 4.72% | 100.0% |
AZN Dividend History
Dividend Monthly Return EX date, 4.8 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
| EX-DATE | RECORD | PAYMENT | PERIOD | DIV/SHARE | GROWTH | PAYOUT YIELD |
|---|---|---|---|---|---|---|
| 2026-08-07 | 2026-08-07 | 2026-09-08 | Semiannual | 1.06 | -51.2% | 0.65% |
| 2026-02-20 | 2026-02-20 | 2026-03-23 | Semiannual | 2.1719 | +321.7% | 1.05% |
| 2025-08-08 | 2025-08-08 | 2025-09-08 | Semiannual | 0.515 | -51% | 0.73% |
| 2025-02-21 | 2025-02-21 | 2025-03-24 | Semiannual | 1.05 | +110% | 1.46% |
| 2024-08-09 | 2024-08-09 | 2024-09-09 | Semiannual | 0.5 | -49.2% | N/A |
| 2024-02-22 | 2024-02-23 | 2024-03-25 | Semiannual | 0.9846 | +115.4% | 1.56% |
| 2023-08-10 | 2023-08-11 | 2023-09-11 | Semiannual | 0.4572 | -53.3% | 0.64% |
| 2023-02-23 | 2023-02-24 | 2023-03-27 | Semiannual | 0.9788 | +109.6% | 1.44% |
| 2022-08-11 | 2022-08-12 | 2022-09-12 | Semiannual | 0.467 | -51.6% | 0.71% |
| 2022-02-24 | 2022-02-25 | 2022-03-28 | Semiannual | 0.9645 | 0% | 1.72% |
AZN Dividend FAQ
As of November 2026, AZN's dividend yield is 1.71%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of 3.23 USD by the current share price of 185.48.
As of November 2026, AZN paid a dividend of 3.23 USD in the last 12 months. The last dividend was paid on 2026-08-07 and the payout was 1.06 USD.
AZN pays dividends semi-annually. Over the last 12 months, AZN has issued 2 dividend payments. The last dividend payment was made on 2026-08-07.
Based on historical data, the forecasted dividends per share for AZN for the next payments are between 1.034 (-2.5%) and 2.347 (+121.4%). This represents a strong dividend growth compared to the last payment. The expected Yield for the next 12 months is about 1.82%.
The latest dividend paid per share was 1.06 USD with an Ex-Dividend Date of 2026-08-07. The next Ex-Dividend date for AstraZeneca (AZN) is currently unknown.
The next Ex-Dividend date for AstraZeneca (AZN) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
AZN's average dividend growth rate over the past 5 years is 3.52% per year. Strong growth: AZN's dividend growth is outpacing inflation.
AZN's 5-Year Yield on Cost is 2.91%. If you bought AZN's shares at 110.96 USD five years ago, your current annual dividend income (3.23 USD per share, trailing 12 months) equals 2.91% of your original purchase price.
AZN Payout Consistency is 100.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number. Very consistent: AstraZeneca has a strong track record of consistent dividend payments over its lifetime.
AZN's 1.71% Dividend Yield is considered as low. This is usually a sign of a growth company.
The Dividend Payout Ratio of AZN is 39.4%. Healthy - Leaves room for growth and provides some protection to maintain dividends even in a recession.
AZN's Overall Dividend Rating is 52.75%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
AZN Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-11-04 02:38 UTC